Start-Ups Swimming ...
Health Care: Drugs
Dynavax Technologies Corporation (DVAX: NASDAQ)
$2.54 0.01 | 0.40%
05/24/13 - 04:00 PM ET
516.28K / 2.53M
Vol / Avg. Vol:2.52 / 2.53
Open / Prev. Close:2.50 - 2.56
Today's Range:1.74 - 5.10
52 Wk Range:-11.23%
Performance YTD:TheStreet Rating:
Portfolios with DVAX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Usercdm1
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
- Contributor10 Stocks Boosting Little F...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
Latest DVAX Headlines from TheStreet
- 5 Stocks Under $5 to Watch 03.13.13 | 07:03 am
- Stocks Waver as Investors Eye Italian Election 02.25.13 | 02:02 pm
- Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejection 02.25.13 | 07:02 am
- Stock Futures Point to Higher Open 02.25.13 | 07:02 am
- Run-Up Trade Into Dynavax's FDA Approval Decision 02.13.13 | 07:02 am
- Dynavax Options Trade For Heplisav FDA Approval Decision 02.12.13 | 08:02 am
- Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics 02.08.13 | 06:02 am
- 5 Stocks Under $10 Ready to Soar Higher 02.07.13 | 01:02 pm
- 'Mad Money' Lightning Round: I'm Avoiding Controversial Coinstar 02.07.13 | 06:02 am
- Cramer's 'Mad Money' Recap: Pay Attention 02.06.13 | 07:02 pm
Press Releases for DVAX
Partner Headlines for DVAX
- Why Dynavax's HEPLISAV Is Likely To Be Approved: Impact On Future Vaccine Development - Seeking Alpha 11.21.12 | 09:11 am
- Mid-Day Markets Update: Markets Recover on Fiscal Cliff Meeting; Casino Stocks Continue to Ramp - Benzinga 11.16.12 | 01:11 pm
- Dynavax Gets Crushed After Advisory Committee Vote - Seeking Alpha 11.16.12 | 09:11 am
- Cramer's Mad Money - 10 Things To Watch In The Week Ahead (9/14/12) - Seeking Alpha 09.16.12 | 06:09 am
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
